0001454815-15-000004.txt : 20151120 0001454815-15-000004.hdr.sgml : 20151120 20151120171947 ACCESSION NUMBER: 0001454815-15-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 EFFECTIVENESS DATE: 20151120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EIGER BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454815 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-251688 FILM NUMBER: 151247537 BUSINESS ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-272-6138 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 D 1 primary_doc.xml X0707 D LIVE 0001454815 EIGER BIOPHARMACEUTICALS INC 350 Cambridge Avenue Suite 350 PALO ALTO CA CALIFORNIA 94306 650-272-6138 DELAWARE None None Corporation true David Cory 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer Director Ed Engleman 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Jeffrey Glenn 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Nina Kjellson 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Thomas Dietz 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Biotechnology Decline to Disclose 06b false 2015-11-12 false true true true false 0 6000000 6000000 0 false 4 0 0 0 false EIGER BIOPHARMACEUTICALS INC /s/ David Cory David Cory President and CEO 2015-11-20